Latest scientific studies and expert articles

Muscle and joint pain is among the most common problems in everyday life. It can occur after physical strain, during sports, after injuries, or in connection with chronic musculoskeletal conditions. Many people therefore look for an effective, locally applicable, and well-tolerated solution that does not unnecessarily burden the body. The ALGYL CBD Pain Relief Patch was developed precisely for this need. It is a locally applied patch containing a combination of cannabidiol (CBD), menthol, and arnica. The formula is designed to target pain directly at the affected area while allowing practical use in everyday life. 

Osteoarthritis (OA) is a degenerative joint disease whose incidence increases with rising average age. It therefore represents a growing challenge for orthopedic practice. In recent years, treatment of this disease has focused not only on pain relief, but also on slowing the progression of cartilage degeneration. In the treatment of OA, intra-articular administration of active substances directly into the affected joint has an important role. Since 2024, the innovative product Algyl GGP has been available in several EU countries (CZ, SK, DE, AT, IT); its concept is based on the latest scientific knowledge of the etiopathogenesis of this disease.

Osteoarthritis is a chronic progressive disease with increasing prevalence. In treatment, after oral pharmacotherapy options have been exhausted, intra-articular therapy is recommended. The efficacy of currently used intra-articular agents, such as corticosteroids, is the subject of professional debate; recommendations from expert societies differ in their position on these agents. Based on the role played in the etiopathogenesis of osteoarthritis by chondrocyte failure, especially failure of extracellular matrix component synthesis, the concept of intra-articular application of collagen and hyaluronic acid in combination with other biogenic substances has emerged. These methods represent a promising therapeutic strategy.